Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Hepatitis B Virus Genotypes in the Kingdom of Bahrain: Prevalence, Gender Distribution and Impact on Hepatic
Essam M Janahi1, Zahra Ilyas2, Sara Al-Othman3
1Department of Biology, College of Science, University of Bahrain, Shakir P.O. Box 32038, Bahrain. essam22@gmail.com.
Insights
Hepatitis B virus (HBV) genotype D is most common in Bahrain, affecting males and non-Bahrainis more. Genotype D correlates with elevated liver enzymes like ALT and GGT.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis B virus (HBV) infection is a global health concern, affecting approximately 400 million people worldwide.
- Limited data exists on HBV genotype prevalence and risk factors in the Kingdom of Bahrain.
- Understanding these factors is crucial for effective disease control and management.
Purpose of the Study:
- To determine the prevalence of different Hepatitis B virus genotypes in Bahrain.
- To investigate the correlation between HBV genotypes and demographic factors.
- To assess the impact of HBV genotypes on hepatic biomarkers.
Main Methods:
- Blood samples from 82 HBV-positive patients were analyzed for HBV DNA extraction and genotyping.
- Genotypes were classified using PCR amplification.
- Statistical analyses (descriptive statistics, ANOVA, t-test) were used to determine associations with demographic factors and liver function tests.
Main Results:
- Hepatitis B virus genotype D was predominant (61%), followed by genotype A (10%).
- No significant associations were found between genotypes and most demographic factors or liver function tests.
- HBV prevalence was higher in males and non-Bahraini individuals. Patients with genotype D showed elevated ALT and GGT levels.
Conclusions:
- Hepatitis B virus genotype D is the most prevalent in Bahrain, followed by genotype A.
- Further research into transmission sources and biomarker impacts is needed for enhanced HBV control in Bahrain.
Abstract:
Background: Approximately 400 million people are infected with Hepatitis B virus (HBV) around the world, which makes it one of the world's major infectious diseases. The prevalence of HBV genotypes and predictive factors for risk are poorly known in the Kingdom of Bahrain. Objectives: The aim of the present study was to investigate the prevalence of HBV genotypes, its correlation with demographic factor sand impacts on hepatic biomarkers. Materials and Methods: Venous blood samples were collected from 82 HBV positive patients (48 males, 34 females). The extraction of HBV DNA, PCR amplification, and genotyping were done to classify different genotypes (A, A/D, B, B/D, C, D, D/E, E). HBV genotypes association with gender, nationality, mode of transmission, and liver cirrhosis complication was determined by descriptive statistic and univariate analysis of variance (ANOVA). For liver function test, unpaired t-test and ANOVA were performed. Results: The predominant genotype among patients under study was genotype D (61%), followed by genotype A (10%), and lowest frequency was found for undetermined genotype (1%). In general, there was no significant association between the different genotypes and some demographical factors, serological investigations, and liver function test. The prevalence of HBV genotypes was higher in male patients as compared to female patients and higher in non-Bahraini than in Bahraini. Patients with the dominant genotype D showed higher than the normal maximum range for alanine aminotransferase (ALT) (mean = 45.89) and Gamma-glutamyl transferase (GGT) (mean = 63.36). Conclusions: The most common HBV genotype in Bahrain was genotype D, followed by genotype A. Further studies involving the sources of transmission and impact of hepatic biomarker in Bahrain are required to enhance the control measures of HBV infections.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Probability Laws
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pedigree Analysis
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

